✦ LIBER ✦

Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS®MPH

✍ Scribed by H. Remschmidt; P. Hoare; C. Ettrich; A. Rothenberger; P. Santosh; M. Schmidt; Q. Spender; R. Tamhne; M. Thompson; C. Tinline; G. E. Trott; R. Medori

Publisher: Springer
Year: 2005
Tongue: English
Weight: 275 KB
Volume: 14
Category: Article
ISSN: 1018-8827
DOI: 10.1007/s00787-005-0467-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Switching from methylphenidate immediate

Switching from methylphenidate immediate release to MPH-SODAS™ in attention-deficit/hyperactivity disorder

✍ Carlos Renato Moreira Maia; Breno Córdova Matte; Henrique Tschoepke Ludwig; Luis 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 255 KB

12-month efficacy and safety of OROS®MPH

12-month efficacy and safety of OROS®MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH

✍ Peter Hoare; H. Remschmidt; R. Medori; C. Ettrich; A. Rothenberger; P. Santosh; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 213 KB